Michot, Jean-Marie <br/><br/>
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.  [electronic resource] 

 -  American journal of hematology  Mar 2015 
 - 197-203 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-8652 
<br/><br/><label>Standard No.: </label>10.1002/ajh.23889  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Antiviral Agents--therapeutic use<br/>Cryoglobulinemia--physiopathology<br/>Female<br/>Hepatitis C--complications<br/>Humans<br/>Lymphoma, B-Cell, Marginal Zone--complications<br/>Lymphoma, Large B-Cell, Diffuse--complications<br/>Male<br/>Middle Aged<br/>Rheumatoid Factor--blood<br/>Survival Analysis<br/>Treatment Outcome